CSafe Opens Facility in Puerto Rico

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-08-03-2016
Volume 11
Issue 8

The company opened a new service center in San Juan, Puerto Rico.

On July 18, 2016, CSafe Global announced that it has opened a new service center in San Juan, Puerto Rico. The company procured multiple 747F charter aircrafts to move multiple CSafe RKN ULDs to the facility. According to CSafe, the containers will be used to support the country’s global manufacturing industry. CSafe’s passive and small active solutions will also be available for use at the new Puerto Rican Facility.

Source: CSafe Global

 

Articles in this issue
PT0716_Outsource_Figure_1-New-1469999787425.jpg
Slower Bio/Pharma Investment Could Hurt CDMOs in 2017
Supply Chain Partner Scrutiny Moves Beyond GMPs
Supply Chain Partner Scrutiny Moves Beyond GMPs
Chiral Advances Demonstrate Promise for API Synthesis
Chiral Advances Demonstrate Promise for API Synthesis
NIST Issues mAb Reference Standard
Saneca Pharma Secures Contract Manufacturing Agreement with Xantis Pharma
EMA Suspends Drugs Due to Flawed Bioequivalence Studies
CordenPharma Expands into Oligonucleotide APIs
Shimadzu System Combines HPLC and UHPLC Methods
Catalent to Commercially Supply Palatin FSD Pen Injectors
Zenith Appoints Serialization Director
CSafe Opens Facility in Puerto Rico
Recipharm Expands Blow-Fill-Seal Capacity at France Facility
Packaging Facility Gets FDA Warning Letter
Vetter Plans Expansion in Illinois
Cambrex Corporation Completes Expansion at Iowa Facility
Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Beckman Coulter Life Sciences Launches Modular Spectral Flow Cytometry Module, First of Its Kind in Industry

Feliza Mirasol
March 28th 2025
Article

The CytoFLEX mosaic Spectral Detection Module offers up to 88 channels for detection.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Sherwin-Williams to Showcase Next-Gen Coatings for Pharma Cleanrooms at INTERPHEX 2025

Feliza Mirasol
March 28th 2025
Article

Sherwin-Williams’ advanced coating systems are designed to ensure safety, sterility, and efficiency in pharma manufacturing environments.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
November 14th 2023
Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Issues Warning Letter to Aspen Biopharma Labs for API Manufacturing Deviations

Feliza Mirasol
March 27th 2025
Article

In the latest of a series of warning letters to India-based API manufacturers, FDA issued a warning letter to Aspen for deviations in CGMP in the production of APIs.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

BIO Survey: Tariffs May Reduce Access, Delay Innovation, Create Red Tape

Patrick Lavery
March 27th 2025
Article

The Biotechnology Innovation Organization’s new membership survey said that 90% of US biotech companies rely on imported components for at least half of their FDA-approved products.